These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

911 related articles for article (PubMed ID: 25269698)

  • 1. Obesity and risk of esophageal adenocarcinoma and Barrett's esophagus: a Mendelian randomization study.
    Thrift AP; Shaheen NJ; Gammon MD; Bernstein L; Reid BJ; Onstad L; Risch HA; Liu G; Bird NC; Wu AH; Corley DA; Romero Y; Chanock SJ; Chow WH; Casson AG; Levine DM; Zhang R; Ek WE; MacGregor S; Ye W; Hardie LJ; Vaughan TL; Whiteman DC
    J Natl Cancer Inst; 2014 Nov; 106(11):. PubMed ID: 25269698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determining Risk of Barrett's Esophagus and Esophageal Adenocarcinoma Based on Epidemiologic Factors and Genetic Variants.
    Dong J; Buas MF; Gharahkhani P; Kendall BJ; Onstad L; Zhao S; Anderson LA; Wu AH; Ye W; Bird NC; Bernstein L; Chow WH; Gammon MD; Liu G; Caldas C; Pharoah PD; Risch HA; Iyer PG; Reid BJ; Hardie LJ; Lagergren J; Shaheen NJ; Corley DA; Fitzgerald RC; ; Whiteman DC; Vaughan TL; Thrift AP
    Gastroenterology; 2018 Apr; 154(5):1273-1281.e3. PubMed ID: 29247777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. No Association Between Vitamin D Status and Risk of Barrett's Esophagus or Esophageal Adenocarcinoma: A Mendelian Randomization Study.
    Dong J; Gharahkhani P; Chow WH; Gammon MD; Liu G; Caldas C; Wu AH; Ye W; Onstad L; Anderson LA; Bernstein L; Pharoah PD; Risch HA; Corley DA; Fitzgerald RC; ; Iyer PG; Reid BJ; Lagergren J; Shaheen NJ; Vaughan TL; MacGregor S; Love S; Palles C; Tomlinson I; Gockel I; May A; Gerges C; Anders M; Böhmer AC; Becker J; Kreuser N; Thieme R; Noder T; Venerito M; Veits L; Schmidt T; Schmidt C; Izbicki JR; Hölscher AH; Lang H; Lorenz D; Schumacher B; Mayershofer R; Vashist Y; Ott K; Vieth M; Weismüller J; Nöthen MM; Moebus S; Knapp M; Peters WHM; Neuhaus H; Rösch T; Ell C; Jankowski J; Schumacher J; Neale RE; Whiteman DC; Thrift AP
    Clin Gastroenterol Hepatol; 2019 Oct; 17(11):2227-2235.e1. PubMed ID: 30716477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of esophageal adenocarcinoma decreases with height, based on consortium analysis and confirmed by Mendelian randomization.
    Thrift AP; Risch HA; Onstad L; Shaheen NJ; Casson AG; Bernstein L; Corley DA; Levine DM; Chow WH; Reid BJ; Romero Y; Hardie LJ; Liu G; Wu AH; Bird NC; Gammon MD; Ye W; Whiteman DC; Vaughan TL
    Clin Gastroenterol Hepatol; 2014 Oct; 12(10):1667-76.e1. PubMed ID: 24530603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Applying big GWAS data to clarify the role of obesity in Barrett's esophagus and esophageal adenocarcinoma.
    Abrams JA; Chak A
    J Natl Cancer Inst; 2014 Nov; 106(11):. PubMed ID: 25269700
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical characteristics of young patients with early Barrett's neoplasia.
    Iwaya Y; Shimamura Y; Goda K; Rodríguez de Santiago E; Coneys JG; Mosko JD; Kandel G; Kortan P; May G; Marcon N; Teshima C
    World J Gastroenterol; 2019 Jun; 25(24):3069-3078. PubMed ID: 31293342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Global DNA methylation patterns in Barrett's esophagus, dysplastic Barrett's, and esophageal adenocarcinoma are associated with BMI, gender, and tobacco use.
    Kaz AM; Wong CJ; Varadan V; Willis JE; Chak A; Grady WM
    Clin Epigenetics; 2016; 8():111. PubMed ID: 27795744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Barrett associated MHC and FOXF1 variants also increase esophageal carcinoma risk.
    Dura P; van Veen EM; Salomon J; te Morsche RH; Roelofs HM; Kristinsson JO; Wobbes T; Witteman BJ; Tan AC; Drenth JP; Peters WH
    Int J Cancer; 2013 Oct; 133(7):1751-5. PubMed ID: 23504527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sex-Specific Genetic Associations for Barrett's Esophagus and Esophageal Adenocarcinoma.
    Dong J; Maj C; Tsavachidis S; Ostrom QT; Gharahkhani P; Anderson LA; Wu AH; Ye W; Bernstein L; Borisov O; Schröder J; Chow WH; Gammon MD; Liu G; Caldas C; Pharoah PD; Risch HA; May A; Gerges C; Anders M; Venerito M; Schmidt T; Izbicki JR; Hölscher AH; Schumacher B; Vashist Y; Neuhaus H; Rösch T; Knapp M; Krawitz P; Böhmer A; Iyer PG; Reid BJ; Lagergren J; Shaheen NJ; Corley DA; Gockel I; Fitzgerald RC; ; Cook MB; Whiteman DC; Vaughan TL; Schumacher J; Thrift AP
    Gastroenterology; 2020 Dec; 159(6):2065-2076.e1. PubMed ID: 32918910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactions Between Genetic Variants and Environmental Factors Affect Risk of Esophageal Adenocarcinoma and Barrett's Esophagus.
    Dong J; Levine DM; Buas MF; Zhang R; Onstad L; Fitzgerald RC; ; Corley DA; Shaheen NJ; Lagergren J; Hardie LJ; Reid BJ; Iyer PG; Risch HA; Caldas C; Caldas I; Pharoah PD; Liu G; Gammon MD; Chow WH; Bernstein L; Bird NC; Ye W; Wu AH; Anderson LA; MacGregor S; Whiteman DC; Vaughan TL; Thrift AP
    Clin Gastroenterol Hepatol; 2018 Oct; 16(10):1598-1606.e4. PubMed ID: 29551738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A newly identified susceptibility locus near FOXP1 modifies the association of gastroesophageal reflux with Barrett's esophagus.
    Dai JY; de Dieu Tapsoba J; Buas MF; Onstad LE; Levine DM; Risch HA; Chow WH; Bernstein L; Ye W; Lagergren J; Bird NC; Corley DA; Shaheen NJ; Wu AH; Reid BJ; Hardie LJ; Whiteman DC; Vaughan TL
    Cancer Epidemiol Biomarkers Prev; 2015 Nov; 24(11):1739-47. PubMed ID: 26377193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A functional epidermal growth factor (EGF) polymorphism, EGF serum levels, and esophageal adenocarcinoma risk and outcome.
    Lanuti M; Liu G; Goodwin JM; Zhai R; Fuchs BC; Asomaning K; Su L; Nishioka NS; Tanabe KK; Christiani DC
    Clin Cancer Res; 2008 May; 14(10):3216-22. PubMed ID: 18483390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of educational attainment with esophageal cancer, Barrett's esophagus, and gastroesophageal reflux disease, and the mediating role of modifiable risk factors: A Mendelian randomization study.
    Zhang X; Yang X; Zhang T; Yin X; Man J; Lu M
    Front Public Health; 2023; 11():1022367. PubMed ID: 37056646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Shared Genetic Etiology of Obesity-Related Traits and Barrett's Esophagus/Adenocarcinoma: Insights from Genome-Wide Association Studies.
    Böhmer AC; Hecker J; Schröder J; Gharahkhani P; May A; Gerges C; Anders M; Becker J; Hess T; Kreuser N; Thieme R; Noder T; Venerito M; Veits L; Schmidt T; Fuchs C; Izbicki JR; Hölscher AH; Dietrich A; Moulla Y; Lyros O; Lang H; Lorenz D; Schumacher B; Mayershofer R; Vashist Y; Ott K; Vieth M; Weismüller J; Moebus S; Knapp M; Neuhaus H; Rösch T; Ell C; Nöthen MM; Whiteman DC; Tomlinson I; Jankowski J; Fitzgerald RC; Palles C; Vaughan TL; Gockel I; Thrift AP; Fier H; Schumacher J
    Cancer Epidemiol Biomarkers Prev; 2020 Feb; 29(2):427-433. PubMed ID: 31748258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association Between Levels of Sex Hormones and Risk of Esophageal Adenocarcinoma and Barrett's Esophagus.
    Xie SH; Fang R; Huang M; Dai J; Thrift AP; Anderson LA; Chow WH; Bernstein L; Gammon MD; Risch HA; Shaheen NJ; Reid BJ; Wu AH; Iyer PG; Liu G; Corley DA; Whiteman DC; Caldas C; Pharoah PD; Hardie LJ; Fitzgerald RC; Shen H; Vaughan TL; Lagergren J
    Clin Gastroenterol Hepatol; 2020 Nov; 18(12):2701-2709.e3. PubMed ID: 31756444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology of Barrett's Esophagus and Esophageal Adenocarcinoma.
    Runge TM; Abrams JA; Shaheen NJ
    Gastroenterol Clin North Am; 2015 Jun; 44(2):203-31. PubMed ID: 26021191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphisms in genes in the androgen pathway and risk of Barrett's esophagus and esophageal adenocarcinoma.
    Ek WE; Lagergren K; Cook M; Wu AH; Abnet CC; Levine D; Chow WH; Bernstein L; Risch HA; Shaheen NJ; Bird NC; Corley DA; Hardie LJ; Fitzgerald RC; Gammon MD; Romero Y; Liu G; Ye W; Vaughan TL; MacGregor S; Whiteman DC; Westberg L; Lagergren J
    Int J Cancer; 2016 Mar; 138(5):1146-52. PubMed ID: 26414697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genes of the interleukin-18 pathway are associated with susceptibility to Barrett's esophagus and esophageal adenocarcinoma.
    Babar M; Ryan AW; Anderson LA; Segurado R; Turner G; Murray LJ; Murphy SJ; Johnston BT; Comber H; Reynolds JV; McManus R
    Am J Gastroenterol; 2012 Sep; 107(9):1331-41. PubMed ID: 22664470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and Validation of a Model to Determine Risk of Progression of Barrett's Esophagus to Neoplasia.
    Parasa S; Vennalaganti S; Gaddam S; Vennalaganti P; Young P; Gupta N; Thota P; Cash B; Mathur S; Sampliner R; Moawad F; Lieberman D; Bansal A; Kennedy KF; Vargo J; Falk G; Spaander M; Bruno M; Sharma P
    Gastroenterology; 2018 Apr; 154(5):1282-1289.e2. PubMed ID: 29273452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-1 RN polymorphism is not associated with Barrett's esophagus and esophageal adenocarcinoma.
    Moons LM; Siersema PD; Kuipers EJ; van Vliet AH; Kusters JG
    Am J Gastroenterol; 2005 Dec; 100(12):2818. PubMed ID: 16393246
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 46.